# GE Vernova Inc.: overview

GEV · NYSE · CIK 1996810 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gev.md) · [Financials](/companies/gev/financials.md) · [Filings](/companies/gev/filings.md) · [Insiders](/companies/gev/insiders.md)

Latest reported revenue: [$12.64bn](/filings/0001996810-26-000163.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 28, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001996810-26-000163).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.6 d](/filings/0001996810-26-000015.md) | [8.0](/filings/0001996810-26-000064.md) | [9.1](/filings/0001996810-26-000148.md) | [10.0](/filings/0001996810-26-000163.md) | [11.0 d](/filings/0001996810-26-000015.md) | [9.3](/filings/0001996810-26-000064.md) | [11.1](/filings/0001996810-26-000148.md) | [12.6](/filings/0001996810-26-000163.md) |
| Gross margin | % | [20.1% d](/filings/0001996810-26-000015.md) | [18.3%](/filings/0001996810-26-000064.md) | [20.3%](/filings/0001996810-26-000148.md) | [19.0%](/filings/0001996810-26-000163.md) | [21.2% d](/filings/0001996810-26-000015.md) | [19.1%](/filings/0001996810-26-000064.md) | [21.3%](/filings/0001996810-26-000148.md) | [24.6%](/filings/0001996810-26-000163.md) |
| Operating margin | % | [5.6% d](/filings/0001996810-26-000015.md) | [0.5%](/filings/0001996810-26-000064.md) | [4.1%](/filings/0001996810-26-000148.md) | [3.7%](/filings/0001996810-26-000163.md) | [5.5% d](/filings/0001996810-26-000015.md) | [1.9%](/filings/0001996810-26-000064.md) | [5.9%](/filings/0001996810-26-000148.md) | [11.0%](/filings/0001996810-26-000163.md) |
| Net margin | % | [4.6% d](/filings/0001996810-26-000015.md) | [3.2%](/filings/0001996810-26-000064.md) | [5.6%](/filings/0001996810-26-000148.md) | [4.5%](/filings/0001996810-26-000163.md) | [33.4% d](/filings/0001996810-26-000015.md) | [50.8%](/filings/0001996810-26-000064.md) | [6.0%](/filings/0001996810-26-000148.md) | [10.2%](/filings/0001996810-26-000163.md) |
| Diluted EPS | $ per share | not reported | [0.91](/filings/0001996810-26-000064.md) | [1.86](/filings/0001996810-26-000148.md) | [1.64](/filings/0001996810-26-000163.md) | not reported | [17.44](/filings/0001996810-26-000064.md) | [2.47](/filings/0001996810-26-000148.md) | [4.81](/filings/0001996810-26-000163.md) |
| Free cash flow | $bn | [0.6 d](/filings/0001996810-26-000015.md) | [1.0](/filings/0001996810-26-000064.md) | [0.2 d](/filings/0001996810-26-000148.md) | [0.7 d](/filings/0001996810-26-000163.md) | [1.8 d](/filings/0001996810-26-000015.md) | [4.8](/filings/0001996810-26-000064.md) | [5.1 d](/filings/0001996810-26-000148.md) | [5.4 d](/filings/0001996810-26-000163.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $bn | [29.7](/filings/0001996810-25-000011.md) | [33.2](/filings/0001996810-26-000015.md) | [34.9](/filings/0001996810-26-000015.md) | [38.1](/filings/0001996810-26-000015.md) |
| Gross margin | % | [11.7%](/filings/0001996810-25-000011.md) | [14.5%](/filings/0001996810-26-000015.md) | [17.4%](/filings/0001996810-26-000015.md) | [19.8%](/filings/0001996810-26-000015.md) |
| Operating margin | % | [(9.7%)](/filings/0001996810-25-000011.md) | [(2.8%)](/filings/0001996810-26-000015.md) | [1.3%](/filings/0001996810-26-000015.md) | [3.6%](/filings/0001996810-26-000015.md) |
| Net margin | % | [(9.2%)](/filings/0001996810-25-000011.md) | [(1.3%)](/filings/0001996810-26-000015.md) | [4.4%](/filings/0001996810-26-000015.md) | [12.8%](/filings/0001996810-26-000015.md) |
| Diluted EPS | $ per share | [(10.00)](/filings/0001996810-25-000011.md) | [(1.60)](/filings/0001996810-26-000015.md) | [5.58](/filings/0001996810-26-000015.md) | [17.69](/filings/0001996810-26-000015.md) |
| Free cash flow | $bn | [(0.6)](/filings/0001996810-25-000011.md) | [0.4](/filings/0001996810-26-000015.md) | [1.7](/filings/0001996810-26-000015.md) | [3.7](/filings/0001996810-26-000015.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gev/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $25.57bn | 21,763,980 |  | Added +1,037,370 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $20.62bn | 17,552,000 |  | Added +35,400 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $18.97bn | 16,150,499 |  | Reduced −2,186,436 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $13.83bn | 11,765,340 |  | Added +370,842 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.44bn | 6,346,988 |  | Reduced −38,090 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $6.89bn | 6,253,305 |  | Reduced −499,658 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $6.72bn | 5,715,959 |  | Reduced −653,764 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $5.88bn | 5,007,405 |  | Added +744,545 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $5.55bn | 4,723,958 |  | Reduced −74,278 |
| [Fisher Asset Management, LLC](/funds/850529.md) | 2026-06-30 | $4.18bn | 3,559,479 |  | Added +3,555,530 |

## Recent filings

[All 208 filings](/companies/gev/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 06:19 ET | [10-Q](/filings/0001996810-26-000163.md) | Quarterly report, period 2026-09-30 | 0001996810-26-000163 |
| 2026-10-28 | 06:16 ET | [8-K](/filings/0001996810-26-000162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001996810-26-000162 |
| 2026-08-27 | 16:20 ET | [8-K](/filings/0001996810-26-000153.md) | 5.02 Departure or appointment of officers or directors | 0001996810-26-000153 |
| 2026-07-22 | 06:27 ET | [10-Q](/filings/0001996810-26-000148.md) | Quarterly report, period 2026-06-30 | 0001996810-26-000148 |
| 2026-07-22 | 06:25 ET | [8-K](/filings/0001996810-26-000147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001996810-26-000147 |
| 2026-05-22 | 17:17 ET | [8-K](/filings/0001996810-26-000115.md) | 5.07 Shareholder vote results | 0001996810-26-000115 |
| 2026-04-22 | 06:27 ET | [10-Q](/filings/0001996810-26-000064.md) | Quarterly report, period 2026-03-31 | 0001996810-26-000064 |
| 2026-04-22 | 06:25 ET | [8-K](/filings/0001996810-26-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001996810-26-000063 |
| 2026-04-03 | 07:00 ET | [DEF 14A](/filings/0001996810-26-000049.md) | Proxy statement, period 2026-05-20 | 0001996810-26-000049 |
| 2026-02-04 | 17:23 ET | [8-K](/filings/0001140361-26-003735.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-003735 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001996810-26-000015.md), filed Jan 29, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/8ef7127f-d71c-48a5-959b-e081f5af6fdf)

## About the filer

- CIK: 1996810
- Tickers: GEV
- Exchange: NYSE
- SIC code: 3600 Electronic & Other Electrical Equipment (No Computer Equip)
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 07:27 ET. No prices; not investment advice.